Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
The Breast Journal|May 12, 2001
Collaborative Initiatives in the Care of Early Stage Breast Cancer: Reduction in Variation of Breast-Conserving TherapyKurt S. Elward, Lynne T. Penberthy, Harry D. Bear, et al.
Scientific Reports|June 30, 2022
Neighborhood disadvantage and biological aging biomarkers among breast cancer patientsJie Shen, Bernard F Fuemmeler, Vanessa B Sheppard, et al.
Plos One|July 16, 2015
Perceived Stress Levels, Chemotherapy, Radiation Treatment and Tumor Characteristics Are Associated with a Persistent Increased Frequency of Somatic Chromosomal Instability in Women Diagnosed with Breast Cancer: A One Year Longitudinal StudyNoran Aboalela, Debra Lyon, R K Elswick, et al.
Surgery|March 16, 2013
Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burdenOmar M Rashid, Masayuki Nagahashi, Subramaniam Ramachandran, et al.
British Journal of Cancer|December 15, 2025
Targeting Bcl-xL to eliminate chemotherapy-induced tumor dormancy and prevent breast cancer metastasisKinjal Gupta, Nicholas Koelsch, Victoria Neely, et al.
Breast Cancer Research and Treatment|February 16, 2010
Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cellsXu Di, Chris Gennings, Harry D Bear, et al.
Molecular Cancer Research : MCR|June 23, 2011
Methyl-binding domain protein 2-dependent proliferation and survival of breast cancer cellsOmar Y Mian, Shou Zhen Wang, Sheng Zu Zhu, et al.
Journal of Surgical Oncology|September 23, 2003
Breast conservation therapy rates are no different in medically indigent versus insured patients with early stage breast cancerMaryam Parviz, Jay Brian Cassel, Brian J Kaplan, et al.
International Immunology|July 21, 2004
Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytesCynthia S Chin, Catriona H T Miller, Laura Graham, et al.
Cancer Immunology, Immunotherapy : CII|July 16, 2016
DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancerKrista P Terracina, Laura J Graham, Kyle K Payne, et al.
Pageof 9